Implementation of all oral 24 weeks regimen for DR-TB patients
-
Locations
-
Topics
-
Methodology
-
ReferenceOCA021-21
Purpose of study
Purpose of study
New all-oral shorter MDR/RR-TB treatment regimens can be used by national TB programmes under operational research conditions. The BPaML regimen has been shown to be safe and effective in the PRACTECAL clinical trial. This study proposal is for a ...
-
Concept
-
Protocol & ERB
-
Implementation
-
Completion
-
Archived
Study timeline
-
ERB supporting documents added by Animesh Sinha
26th January 2022MSF_ERB_2180b_ethics_approval_26Jan22.pdf119 KB -
ERB supporting documents added by Animesh Sinha
26th January 2022MSF_ERB_2180c_ethics_approval_26Jan22.pdf120 KB -
Protocol added by Animesh Sinha
24th January 2022SMARRTT_Uzbekistan_v1.1_24Jan2022.docx162 KB -
Protocol added by Animesh Sinha
24th January 2022SMARRTT_Belarus_v1.1_24Jan2022.docx142 KB -
ERB documentation added by Animesh Sinha
8th December 2021MSF_ERB_2180_ethics_approval_08Dec2021.pdf168 KB -
ERB supporting documents added by Animesh Sinha
8th December 2021MSF_ERB_2180a_ethics_approval_08Dec2021.pdf120 KB -
Protocol added by Animesh Sinha
7th December 2021SMARRTT_Protocol_v1.2_of_07Dec2021.docx969 KB -
Protocol added by Animesh Sinha
7th December 2021SMARRTT_Tajikistan_v1.1_of_01Dec2021.docx135 KB -
Concept paper added by Animesh Sinha
18th June 2021Research_Committee_Feedback_PRACTECAL_OR.pdf113 KB -
Concept paper added by Animesh Sinha
18th June 2021Study_concept_paper_PRACTECAL_OR.docx60 KB
Documents
Publications
No publications recorded
Previous study
Next study